Key senator seeks Lilly documents on Zyprexa risks, promotion

04/5/2007 | Forbes

The ranking Republican on the Senate Finance Committee wants Eli Lilly to produce documents for the panel regarding accusations it played down risks of Zyprexa. Several lawsuits against the company claim the drugmaker wrongly promoted Zyprexa, for treating schizophrenia and bipolar disorder, and played down its risks. Sen. Charles Grassley, R-Iowa, wants information similar to that already requested by a House committee.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Compliance Specialist
Brooklyn, NY
Director of Utilization Management
Meridian Health Plan
Chicago, IL
Senior Manager, Healthcare Reform
Avalere Health
Washington, DC
Regulatory Senior Managing/Principal Engineer/Scientist
Menlo Park, CA
Director of Claims
Meridian Health Plan
Detroit, MI